Get the Stockscreener App
15.44
3.09%
-0.40
Tyra Biosciences Inc stock is traded at $15.44, with a volume of 39,821.
It is down -3.09% in the last 24 hours and up +12.37% over the past month.
Tyra Biosciences Inc is a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology. The company's in-house precision medicine platform, SNAP, enables rapid and precise drug design through iterative molecular SNAPshots that help to design and predict which product candidates may demonstrate the highest potency, selectivity, and tolerability in the clinic. The various drug candidates in the company's product pipeline are TYRA-300, TYRA-200, and TYRA-430: three clinical-stage, novel small molecules designed to overcome the toxicity and resistance liabilities of first-generation pan-FGFR inhibitors.
See More
Previous Close:
$15.84
Open:
$15.68
24h Volume:
39,821
Relative Volume:
0.18
Market Cap:
$818.64M
Revenue:
-
Net Income/Loss:
$-83.74M
P/E Ratio:
-9.5901
EPS:
-1.61
Net Cash Flow:
$-64.98M
1W Performance:
+3.44%
1M Performance:
+12.37%
6M Performance:
+41.34%
1Y Performance:
-6.35%
1-Day Range:
$15.21
$15.99
1-Week Range:
$14.32
$16.05
52-Week Range:
$6.42
$17.78
Tyra Biosciences Inc Stock (TYRA) Company Profile
Name
Tyra Biosciences Inc
Sector
Industry
Phone
(619) 728-4760
Address
2656 STATE STREET, CARLSBAD
Compare TYRA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TYRA
Tyra Biosciences Inc
|
15.36 | 844.23M | 0 | -83.74M | -64.98M | -1.61 |
|
VRTX
Vertex Pharmaceuticals Inc
|
420.08 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
632.00 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
433.70 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
812.76 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
181.09 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Tyra Biosciences Inc Stock (TYRA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-03-25 | Initiated | Raymond James | Strong Buy |
| May-21-25 | Resumed | Piper Sandler | Overweight |
| Jan-07-25 | Initiated | UBS | Buy |
| Oct-18-24 | Upgrade | BofA Securities | Neutral → Buy |
| Aug-15-24 | Initiated | Piper Sandler | Overweight |
| Dec-15-23 | Downgrade | BofA Securities | Buy → Neutral |
| Jun-30-23 | Initiated | Wedbush | Outperform |
| Feb-03-23 | Initiated | Oppenheimer | Outperform |
| Jun-23-22 | Initiated | H.C. Wainwright | Buy |
| Mar-08-22 | Upgrade | Jefferies | Hold → Buy |
| Nov-08-21 | Downgrade | Jefferies | Buy → Hold |
| Oct-11-21 | Initiated | BofA Securities | Buy |
| Oct-11-21 | Initiated | Cowen | Outperform |
| Oct-11-21 | Initiated | Jefferies | Buy |
View All
Tyra Biosciences Inc Stock (TYRA) Latest News
Does Tyra Biosciences Inc. fit your quant trading modelQuarterly Performance Summary & Expert-Curated Trade Recommendations - newser.com
Will Tyra Biosciences Inc. stock rally after Fed decisionsTrade Entry Report & High Conviction Trade Alerts - newser.com
Is Tyra Biosciences Inc. stock attractive for long term wealth building2025 Major Catalysts & Growth Focused Entry Reports - newser.com
Can technical indicators confirm Tyra Biosciences Inc.’s reversalPortfolio Return Report & Entry and Exit Point Strategies - newser.com
Historical volatility pattern of Tyra Biosciences Inc. visualizedEarnings Miss & Expert Verified Movement Alerts - newser.com
Tyra Biosciences, Inc. (NASDAQ:TYRA) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Heatmap analysis for Tyra Biosciences Inc. and competitorsEarnings Beat & Accurate Technical Buy Alerts - newser.com
Risk vs reward if holding onto Tyra Biosciences Inc.2025 Biggest Moves & Step-by-Step Swing Trade Plans - newser.com
How Tyra Biosciences Inc. stock performs during Fed tightening cyclesOil Prices & Weekly Watchlist for Consistent Profits - newser.com
Is Tyra Biosciences Inc. stock poised for growthQuarterly Earnings Summary & Long-Term Capital Growth Ideas - newser.com
Tyra Biosciences (TYRA) Projected to Post Earnings on Thursday - MarketBeat
Signal strength of Tyra Biosciences Inc. stock in tech scanners2025 Performance Recap & High Conviction Investment Ideas - newser.com
Will Tyra Biosciences Inc. continue its uptrendJuly 2025 Closing Moves & Free Low Drawdown Momentum Trade Ideas - newser.com
AlphaQuest LLC Has $699,000 Stock Holdings in Tyra Biosciences, Inc. $TYRA - MarketBeat
What’s the recovery path for long term holders of Tyra Biosciences Inc.Quarterly Investment Review & Capital Protection Trade Alerts - newser.com
Tyra Biosciences backs cancer forum to advance urologic oncology - Traders Union
Tyra Biosciences Inc Stock (TYRA) Financials Data
Revenue
Net Income
Cash Flow
EPS
Tyra Biosciences Inc Stock (TYRA) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| KAPLAN GILLA | Director |
Jun 17 '25 |
Sale |
10.35 |
10 |
104 |
37,799 |
0.66%
0.84%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):